Boldenone Undecylenate is a clear pale yellow sterile liquid for intramuscular use. Each ml contains Boldenone Undecylenate 200mg. Boldenone Undecylenate is yellow to pale yellow oily liquid, it is odourless or has a slight characteristic odour it is insoluble in water, very soluble in vegetable oils, ethanol, chloroform, acetone and dioxane. Its empirical formula is C30H40O3 and molecular weight is 452.68.
Anabolic steroids promote muscular tissue building processes and can reverse catabolism in the presence of adequate protein and calories. Endogenous testosterone release may be suppressed by inhibiting lutenizing hormone (LH). Large doses can impede spermatogenesis by negative feedback inhibition of FSH. Anabolic steroids can also stimulate erythropoiesis. The mechanism for this effect may occur by stimulating erythropoeitic stimulating factor, stimulates the release of erythropoietin in the kidneys. Anabolics can cause nitrogen, sodium, potassium and phosphorus retention and decrease the urinary excretion of calcium. The activity of boldenone is mainly anabolic, with a low androgenic potency.
Boldenone Undecylenate is considered to be a long-acting anabolic, with effects persisting for up to 8 weeks. It has a very long half-life, and can show up on a steroid test for up to 1.5 years, due to the undecylenate ester attached to the parent steroid. Trace amounts of the drug can easily be detected for months after discontinued use.
Boldenone Undecylenate is used to promote weight gain following extensive surgery, chronic infection, or severe trauma, and in other cases that result in inadequate weight gain or maintenance. It is also used to decrease muscle loss caused by treatment with corticosteroids and to reduce bone pain associated with osteoporosis.
Boldenone Undecylenate injections are only to be administered intramuscularly. In order to maintain stable blood levels, Boldenone Undecylenate should be injected at least once per week. It is most commonly used at a dosage of 400-600mg per week for men, 50-150 mg per week for women.
Although commonly compared to nandrolone, Boldenone lacks progesterone receptor interaction and all the associated progestinic side effects. Boldenone can, however, produce mild androgenic side effects such as oily skin, acne, increased aggression, enlarging penis, increased frequency of erections, enlarging clitoris, hoarseness or deepening of voice, irregular menstrual periods, unnatural hair growth, unusual hair loss. Seek medical attention right away if any of these SEVERE side effects occur: Bone pain, nausea or vomiting, sore tongue, swelling of feet or lower legs, unusual bleeding, unusual weight gain, Black, tarry, or light-colored stools, dark-colored urine, purple- or red-colored spots on body or inside the mouth or nose, sore throat and/or fever, vomiting of blood. Boldenone does reduce to a more potent androgen dihydroboldenone via the 5-alpha-reductase enzyme (analogous to fee conversion of testosterone to dihydrotestosterone (DHT), however its affinity for this interaction in the human body is low to nonexistent. Suppression of the UPTA, water retention, possible increase in acne and possible conversion to estrogen, high blood pressure are all side effects associated with Boldenone.
Boldenone should not used in patients with known hypersensitivity to Boldenone or any of its exeipients. It is contraindieated in Infant, pregnancy, Lactating mothers as Boldenone supplements causes fetal harm.
Oral hypoglycemic agent and insulin: the metabolic effects of androgens may reduce the blood glucose level & insulin in diabetic patients. Corticosteroids: tendency towards oedema enhanced, use with caution in patients with hepatic or cardiac disease. Anticoagulants: potentiates the effects of anticoagulants. Monitoring of PTs and dosage adjustment, if necessary, of the anticoagulant are recommended. Drug/Laboratory interactions-Concentrations of protein bound iodine (PBI) can be decreased in patients receiving androgen/anabolic therapy, but the clinical significance of this is probably not important. Androgen/anabolic agents can decrease amounts of thyroxine-binding globulin and decrease total T4 concentrations and increase resin uptake of T3 and T4. Free thyroid hormones are unaltered and clinically, there is no evidence of dysfunction. Both creatinine and creatine excretion can be decreased by anabolic steroids. Anabolic steroids can increase the urinary excretion of 17-ketosteroids. Androgenic/anabolic steroids may alter blood glucose levels. Androgenic/anabolic steroids may suppress clotting factors H, V, VH, and X. Anabolic agents can affect liver function tests (BSP retention, SCOT, SGPT, bilirubin, and alkaline phosphatase). Effect of ability to drive and use machines: No research suggests the influence on alertness and concentration.
No information was located for this specific agent, sodium and water retention can occur after overdosage of anabolic steroids. It is suggested to treat supportively and monitor liver function should an inadvertent overdose be administered.
Keep out of the reach and sight of children. Do not store above 30°C. Keep in the original package or container supplied. Do not use this product after the expiry date that is stated in the outer package. The expiry date refers to the last day of the month. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
5 ampoules are packed in a plastic tray. 2 such trays are packed in carton box. All pack sizes may not be marketed.